Urinary bladder cancer

| Main Article
| Discussion
| Definition [?]
| Related Articles  [?]
| Bibliography  [?]
| External Links  [?]
| Citable Version  [?]

|
|
|
|
|
|
|
|
|

This editable Main Article is under development and subject to a disclaimer.

[edit intro]

## Diagnosis[edit]

Urinary biomarkers may not be very sensitive according to a systematic review.[1]

## Screening[edit]

A clinical practice guideline by the U.S. Preventive Services Task Force concludes there is insuficient evidence to recommend screening.[2][3]

## References[edit]

1. ↑ Lotan Y, Roehrborn CG (2003). "Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.". Urology 61 (1): 109-18; discussion 118. PMID 12559279. [e]
2. ↑ Chou R, Dana T (2010). "Screening adults for bladder cancer: a review of the evidence for the U.S. preventive services task force.". Ann Intern Med 153 (7): 461-8. DOI:10.1059/0003-4819-153-7-201010050-00009. PMID 20921545. Research Blogging.
3. ↑ Moyer VA, on behalf of the U.S. Preventive Services Task Force (2011). "Screening for Bladder Cancer: U.S. Preventive Services Task Force Recommendation Statement.". Ann Intern Med 155 (4): 246-251. DOI:10.1059/0003-4819-155-4-201108160-00008. PMID 21844550. Research Blogging.